SK278084B6 - Biological usable agent containing as effective matter methylhydroxyprogesterone acetate and method of its production - Google Patents

Biological usable agent containing as effective matter methylhydroxyprogesterone acetate and method of its production Download PDF

Info

Publication number
SK278084B6
SK278084B6 SK784-85A SK78485A SK278084B6 SK 278084 B6 SK278084 B6 SK 278084B6 SK 78485 A SK78485 A SK 78485A SK 278084 B6 SK278084 B6 SK 278084B6
Authority
SK
Slovakia
Prior art keywords
map
polymer
acetate
cross
swelling
Prior art date
Application number
SK784-85A
Other languages
English (en)
Slovak (sk)
Inventor
Fabio Carli
Original Assignee
Fabio Carli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabio Carli filed Critical Fabio Carli
Publication of SK278084B6 publication Critical patent/SK278084B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SK784-85A 1984-02-08 1985-02-05 Biological usable agent containing as effective matter methylhydroxyprogesterone acetate and method of its production SK278084B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848403360A GB8403360D0 (en) 1984-02-08 1984-02-08 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SK278084B6 true SK278084B6 (en) 1995-12-06

Family

ID=10556300

Family Applications (1)

Application Number Title Priority Date Filing Date
SK784-85A SK278084B6 (en) 1984-02-08 1985-02-05 Biological usable agent containing as effective matter methylhydroxyprogesterone acetate and method of its production

Country Status (32)

Country Link
US (1) US4632828A (es)
JP (1) JPS60181017A (es)
KR (1) KR930009897B1 (es)
AT (1) AT388869B (es)
AU (1) AU577351B2 (es)
BE (1) BE901664A (es)
BG (1) BG60524B2 (es)
CA (1) CA1240928A (es)
CH (1) CH664693A5 (es)
CZ (1) CZ277728B6 (es)
DE (1) DE3503679A1 (es)
DK (1) DK164149C (es)
ES (3) ES8607984A1 (es)
FI (1) FI84230C (es)
FR (1) FR2559065B1 (es)
GB (2) GB8403360D0 (es)
GR (1) GR850312B (es)
HK (1) HK94290A (es)
HU (1) HU194050B (es)
IE (1) IE58230B1 (es)
IL (1) IL74241A (es)
IT (1) IT1209615B (es)
NL (1) NL192780C (es)
NO (1) NO170568C (es)
NZ (1) NZ211058A (es)
PT (1) PT79933B (es)
SE (2) SE8500553L (es)
SG (1) SG80390G (es)
SK (1) SK278084B6 (es)
SU (1) SU1605926A3 (es)
UA (1) UA6028A1 (es)
ZA (1) ZA85943B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005804A1 (en) * 1986-04-01 1987-10-08 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
GB8806367D0 (en) * 1988-03-17 1988-04-13 Erba Carlo Spa Siloxane matrices with internal non-uniform drug distribution
IE60458B1 (en) * 1989-10-26 1994-07-13 Elan Corp Plc Enhanced bioavailability adsorbates
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
WO2000050041A1 (en) * 1999-02-24 2000-08-31 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose
US20020132839A1 (en) * 2000-06-22 2002-09-19 Ganter Sabina Maria Tablet formulations comprising valsartan
AUPS244002A0 (en) * 2002-05-20 2002-06-13 John Kohnke Products Pty Ltd Agent delivery system
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
JP2005094910A (ja) * 2003-09-17 2005-04-07 Aruze Corp モータ停止制御装置

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
AU454482B2 (en) * 1970-11-05 1974-10-15 Alza Corporation Drug-delivery system
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
US4038389A (en) * 1975-05-07 1977-07-26 The Upjohn Company Medroxyprogesterone acetate compositions
DE2634004B2 (de) * 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
CA1098443A (en) * 1977-05-20 1981-03-31 Namassivaya Doddi Absorbable p-dioxanone polymer-drug compositions
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
GB2067900B (en) * 1980-01-25 1983-06-22 Ddsa Pharmaceuticals Ltd Medicinal tablets
DE3006635A1 (de) * 1980-02-22 1981-08-27 Basf Ag, 6700 Ludwigshafen Verwendung von mikronisiertem vernetztem, unloeslichem polyvinylpyrrolidon zur stabilisierung von suspensionen
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
DE3125178A1 (de) * 1981-06-26 1983-01-13 Gödecke AG, 1000 Berlin Verfahren zur zeitlichen steuerung der freisetzung von wirkstoffen aus wirkstoffzubereitungen, insbesondere arzneimittelzubereitungen
DE3205399A1 (de) * 1982-02-16 1983-08-25 Bayer Ag, 5090 Leverkusen Feste, schnellfreisetzende arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
EP0084190A3 (en) * 1981-12-08 1984-11-28 Fisons Plc Medicinal composition, package and method of making the composition
GB2138286B (en) * 1983-04-19 1986-10-08 Dr Christopher Harry Mortimer Pharmaceutical composition for the treatment of hair loss

Also Published As

Publication number Publication date
ES539874A0 (es) 1986-06-01
SE8500553L (sv) 1985-08-09
IE850261L (en) 1985-08-08
FI850455L (fi) 1985-08-09
SG80390G (en) 1990-11-23
NO170568C (no) 1992-11-04
FI84230C (fi) 1991-11-11
AU3848885A (en) 1985-08-15
AU577351B2 (en) 1988-09-22
NO850477L (no) 1985-08-09
IL74241A0 (en) 1985-05-31
FI850455A0 (fi) 1985-02-04
PT79933A (en) 1985-03-01
SE8500553D0 (sv) 1985-02-06
DE3503679A1 (de) 1985-08-08
NL8500323A (nl) 1985-09-02
DK57085A (da) 1985-08-09
DK57085D0 (da) 1985-02-07
GB8503033D0 (en) 1985-03-06
PT79933B (en) 1987-02-02
BG60524B2 (bg) 1995-07-28
IE58230B1 (en) 1993-08-11
CH664693A5 (de) 1988-03-31
GB2153677B (en) 1988-04-13
GB2153677A (en) 1985-08-29
AT388869B (de) 1989-09-11
FR2559065A1 (fr) 1985-08-09
NZ211058A (en) 1988-09-29
ES550614A0 (es) 1987-02-16
ES8703278A1 (es) 1987-02-16
HUT37890A (en) 1986-03-28
DK164149B (da) 1992-05-18
ZA85943B (en) 1985-10-30
IT8519385A0 (it) 1985-02-05
DE3503679C2 (es) 1992-05-07
HU194050B (en) 1988-01-28
BE901664A (fr) 1985-08-06
DK164149C (da) 1992-10-12
NO170568B (no) 1992-07-27
ATA31685A (de) 1989-02-15
SU1605926A3 (ru) 1990-11-07
IT1209615B (it) 1989-08-30
FI84230B (fi) 1991-07-31
NL192780C (nl) 1998-02-03
GB8403360D0 (en) 1984-03-14
ES550613A0 (es) 1987-02-16
HK94290A (en) 1990-11-23
US4632828A (en) 1986-12-30
NL192780B (nl) 1997-10-01
IL74241A (en) 1988-12-30
ES8703277A1 (es) 1987-02-16
CA1240928A (en) 1988-08-23
SE462547B (sv) 1990-07-16
KR850005858A (ko) 1985-09-26
JPH0415769B2 (es) 1992-03-19
FR2559065B1 (fr) 1988-09-09
CS78485A3 (en) 1992-11-18
KR930009897B1 (ko) 1993-10-13
CZ277728B6 (en) 1993-04-14
UA6028A1 (uk) 1994-12-29
ES8607984A1 (es) 1986-06-01
JPS60181017A (ja) 1985-09-14
GR850312B (es) 1985-06-05

Similar Documents

Publication Publication Date Title
US4639370A (en) Pharmaceutical composition
US4344934A (en) Therapeutic compositions with enhanced bioavailability
EP0012523B2 (en) Therapeutic compositions with enhanced bioavailability and process for their preparation
KR100384215B1 (ko) 방출지속성다분산하디로겔시스템-비정질약물
TWI234465B (en) Stable complexes of poorly soluble compounds
AU782282B2 (en) Pharmaceutical composition containing fenofibrate and preparation method
US5980942A (en) Zero-order sustained release matrix tablet formulations of carbamazepine
SK278084B6 (en) Biological usable agent containing as effective matter methylhydroxyprogesterone acetate and method of its production
EP0552708A1 (en) Method of producing a solid dispersion of a sparingly water-soluble drug
CA3019257A1 (en) A pharmaceutical formulation of palbociclib and a preparation method thereof
EP1011640A1 (en) Solid pharmaceutical dosage forms in form of a particulate dispersion
EP1847260B1 (en) Solid dispersion preparation
JPS63165318A (ja) 光の影響に対して安定化したニフェディピン濃縮物及びその製造方法
CN101732235B (zh) 一种枸橼酸他莫昔芬口服固体制剂的制备方法
CN101754750A (zh) 制备包含奥卡西平的控释固体制剂的方法及由所述方法可获得的制剂
WO2022148005A1 (zh) 一种药物固体分散体及其制备方法
JP2023503385A (ja) 非晶質形態の芳香族複素環式化合物を含む組成物、並びにその調製方法及びその使用
GB2153676A (en) Pharmaceutical composition
CN116019815B (zh) 一种头孢托仑匹酯药物组合物及其制备方法
CA1204665A (en) Therapeutic compositions with enhanced bioavailability
MXPA99008648A (es) Complejos estables de compuestos poco solubles